Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2023 is -7.98% vs 4.49% in Mar 2023
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2023 is 29.82% vs 31.92% in Mar 2023
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2023 is 15.26% vs -11.57% in Mar 2023
Interest
QoQ Growth in quarter ended Jun 2023 is 145.45% vs -50.00% in Mar 2023
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2023 has improved from Mar 2023
Compare Quarterly Results Of Sorrento Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2023 is -7.98% vs 4.49% in Mar 2023
YoY Growth in quarter ended Jun 2023 is 30.43% vs -14.81% in Jun 2022
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2023 is 29.82% vs 31.92% in Mar 2023
YoY Growth in quarter ended Jun 2023 is 50.57% vs -31.67% in Jun 2022
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2023 is 15.26% vs -11.57% in Mar 2023
YoY Growth in quarter ended Jun 2023 is 18.74% vs 4.58% in Jun 2022
Quarterly - Interest
QoQ Growth in quarter ended Jun 2023 is 145.45% vs -50.00% in Mar 2023
YoY Growth in quarter ended Jun 2023 is 17.39% vs 15.00% in Jun 2022
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2023 has improved from Mar 2023
YoY Growth in quarter ended Jun 2023 has improved from Jun 2022






